ChemBK
  • Home
  • Product Category
  • CHN
  1. Home
  2. CAS 182410-00-0
  3. Supplier List
  4. MedChemExpress (MCE)
  5. Biochemical Assay Reagents
  6. SBE-β-CD

Request for quotation








Supplier Contact

Supplier NameMedChemExpress (MCE)
Contactsales
Tel609-228-6898
Mobile609-228-6898
QQ
Emailsales@medchemexpress.com; tech@medchemexpress.com
Websitehttps://www.medchemexpress.com/
Wechat
Product Namebeta.-Cyclodextrin, sulfobutyl ethers, sodium salts
SynonymsSBE7-beta-CD
sulfobutyl ether sodium salt
BETADEX SULFOBUTYL ETHER SOIDUM
betadex sulfobuytl ether sodium
β-Cyclodextrin, sulfobutyl ethers
Sodium sulfobutylether β-cyclodextrin
Sulfobutylated beta-cyclodextrin sodium salt (DS~4)

Synonyms

SBE7-beta-CD
sulfobutyl ether sodium salt
BETADEX SULFOBUTYL ETHER SOIDUM
betadex sulfobuytl ether sodium
β-Cyclodextrin, sulfobutyl ethers
Sodium sulfobutylether β-cyclodextrin
Sulfobutylated beta-cyclodextrin sodium salt (DS~4)
Sulfobutylated beta-cyclodextrin sodium salt (DS~6)
beta.-Cyclodextrin, sulfobutyl ethers, sodium salts
.beta.-Cyclodextrin, sulfobutyl ethers, sodium salts
SBE-β-CD(Sulfobutyl Ether-β-cyclodextrin Sodium salt)
CAS182410-00-0;194615-04-8
EINECS1308068-626-2
Chemical FormulaC42H70O35
Molecular Weight1134.9842
inchi
Package500 mg;1 g;5 g;10 g;25 g;50 g
PriceEmail to quote
DescriptionsSBE-β-CD

SBE-β-CD

MedChemExpress (MCE)

HY-17031

182410-00-0

Sulfobutylether-β-Cyclodextrin

99.89%

4°C, sealed storage, away from moisture and light

Room temperature in continental US

Descriptions

SBE-β-CD

SBE-β-CD

MedChemExpress (MCE)

HY-17031

182410-00-0

Sulfobutylether-β-Cyclodextrin

99.89%

4°C, sealed storage, away from moisture and light

Room temperature in continental US
may vary elsewhere.

SBE-β-CD is a sulfobutylether β-cyclodextrin derivative used as an excipient or a formulating agent to increase the solubility of poorly soluble agents.

SBE-β-CD is a chemically modified β-CD that is a cyclic hydrophilic oligosaccharide which is negatively charged in aqueous media. β-CD functioned is a solubilizer only at low concentrations, whereas SBE7-β-CD exhibits strong solubilizing effects over a wide concentration range[1].

20% SBE-β-CD in saline: Guidelines (Following is our recommended protocol. This protocol only provides a guideline, and should be modified according to your specific needs). 1. Dissolve 0.9 g of NaCl in 100 mL distilled water to make a clear 0.9% saline solution. 2. Measure 2 g of dry SBE-β-CD. 3. Dissolve 2 g of SBE-β-CD in 0.9% saline to make 10 mL with a 20% (w/v) concentration. These may require ultrasonic (20-40 kHz, 30 seconds, repeat 3 times) or heating (37°C for about 30 minutes). If precipitation is observed, the precipitates can be dissolved by heating to 37°C and vortexing before use.

Rats[2] A 300 g rat is administered with 1 mL of a 0.1 M SBE-β-CD solution containing 5.64 mg of Compound 1, and assuming an extracellular volume of 90 mL, less than 0.1% of the complex would rapidly dissociate due to the initial effects of dilution. This calculation, combined with the changing blood to plasma ratio in the presence of SBE-β-CD, provides a reasonable explanation for the observed differences in the blood and plasma profiles of Compound 1 after intravenous administration in either the cyclodextrin or cyclodextrin-free formulations. After IV administration of the cyclodextrin formulation, Compound 1 would initially be prevented from distributing into erythrocytes thereby resulting in a whole blood to plasma ratio of less than one. Subsequently, clearance of SBE-β-CD from the circulation would lead to changes in the complexation equilibrium such that the unbound fraction of Compound 1 would increase, thereby reestablishing normal blood to plasma partitioning (i.e. in favour of whole blood) and clearance.

| | | |

| | | | | |



[1]. Fukuda M, et al.Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion.Int J Pharm. 2008 Feb 28
350(1-2):188-196
[Content Brief]

[2]. Charman SA, et al. Alteration of the intravenous pharmacokinetics of a synthetic ozonide antimalarial in the presence of a modified cyclodextrin. J Pharm Sci. 2006 Feb
95(2):256-67
[Content Brief]

Supplier Websitehttps://www.medchemexpress.com/SBE-_beta_-CD.html
Last Update2025-05-21 16:50:25
MedChemExpress (MCE) also provides

LFM-A13

Category: Biochemical Assay Reagents
CAS: 62004-35-7
Last Update: 2025-05-21 16:50:25

2-Ethylhexyl palmitate

Category: Biochemical Assay Reagents
CAS: 29806-73-3
Last Update: 2025-05-21 16:50:25

Boscalid

Category: Biochemical Assay Reagents
CAS: 188425-85-6
Last Update: 2025-05-21 16:50:25

Etilefrine hydrochloride

Category: Biochemical Assay Reagents
CAS: 943-17-9
Last Update: 2025-05-21 16:50:25

N-(2-Aminoethyl)maleimide hydrochloride

Category: Biochemical Assay Reagents
CAS: 134272-64-3
Last Update: 2025-05-21 16:50:25

PTCDA

Category: Biochemical Assay Reagents
CAS: 128-69-8
Last Update: 2025-05-21 16:50:25

ATX-0126

Category: Biochemical Assay Reagents
CAS: 2230647-37-5
Last Update: 2025-05-21 16:50:25

DLin-M-C4-DMA

Category: Biochemical Assay Reagents
CAS: 1226909-66-5
Last Update: 2025-05-21 16:50:25
  • Home
  • Product Category

© 2015 ChemBK.com All Rights Reserved | Build: 20150530002